ERBB2 and breast cancer: Since then ESMO has published more extensive and targeted clinical practice guidelines for BC, primary BC guidelines introduced five BC subtypes and the recommended systemic treatment for these ranging from endocrine therapy or chemotherapy alone or in combination with anti‐HER2 therapy.2